Why Chronic Inflammation Responds to HBOT

Chronic inflammation is a low-grade, persistent immune response that, unlike acute inflammation after an injury, never fully resolves. Over months and years it quietly damages tissues throughout the body, elevating your risk of heart disease, metabolic dysfunction, autoimmune flares, cognitive decline, joint degeneration, and certain cancers. At the cellular level, chronic inflammation is sustained by ongoing release of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β), oxidative stress, mitochondrial dysfunction, and persistent tissue hypoxia. HBOT directly counteracts each of these mechanisms. Under hyperbaric pressure, 100% pure oxygen dissolves into blood plasma and reaches hypoxic tissues that standard circulation cannot adequately supply. This elevated oxygen delivery downregulates pro-inflammatory cytokines, reduces oxidative stress, and stimulates the body’s natural anti-inflammatory responses.

The Science Behind the Protocol.

Published clinical and laboratory research has documented HBOT’s anti-inflammatory effects across multiple measurable endpoints:

• TNF-α and IL-6 reduction: Two key pro-inflammatory cytokines show measurable declines after structured HBOT protocols in multiple peer-reviewed trials.
• C-reactive protein (CRP): The most widely used systemic inflammation marker drops in most patients over a 10–20 session protocol.
• Antioxidant enzyme activity: Glutathione peroxidase, superoxide dismutase, and catalase activity all rise — counteracting the oxidative stress that drives chronic inflammation.
• Stem cell mobilization: HBOT triggers release of stem cells from bone marrow, supporting tissue repair and immune regulation.
• Reduced oxidative damage: Lipid peroxidation and protein carbonyl markers decline across protocols.

These mechanisms, stacked together, make HBOT a unique intervention: rather than simply blocking an inflammatory pathway (the strategy of most anti-inflammatory drugs), it addresses the underlying cellular environment that sustains inflammation.

What a Typical Protocol Looks Like

Most anti-inflammatory HBOT protocols at TrufaMED run 10 to 30 sessions, typically 3–5 sessions per week. Your physician orders baseline inflammatory markers (CRP, ESR, and condition-specific labs) during your initial evaluation and re-checks them mid-protocol and at completion to objectively track your response. Sessions run 60 to 90 minutes at 1.5–2.5 ATA with 100% pure oxygen. All new patients complete a comprehensive physical exam with on-site chest X-ray before the first session to confirm safety. If you have a specific inflammatory condition (fibromyalgia, inflammatory joint pain, autoimmune symptoms, post-viral inflammation), your physician may design a longer protocol with periodic maintenance sessions after the initial course.

What to Expect Session by Session

Sessions 1–3: Cellular Adjustment

Body adapts to pressurized oxygen. Many patients notice subtle improvement in energy or sleep; some feel relaxed fatigue after sessions. Baseline labs drawn.

Sessions 4–10: Early Markers

Subjective reports of reduced pain, stiffness, and brain fog are common. CRP and ESR often begin to decline. Sleep quality frequently improves in this window.

Sessions 11–20: Biomarker Shifts

Mid-protocol lab redraw shows measurable change in most responders. TNF-α and IL-6 drop; antioxidant enzyme activity rises. Your physician reviews progress and may adjust the remaining protocol.

Sessions 21–30: Consolidation

Sustained reduction in inflammation markers; many patients report meaningful functional improvement. End-of-protocol labs document the change.

Pairing HBOT with Complementary Care

HBOT is most effective for chronic inflammation when paired with a broader anti-inflammatory strategy. At TrufaMED we frequently integrate:

• IV Therapy — Myers’ Cocktail, vitamin C, and glutathione IV protocols stack powerfully with HBOT.
• Red Light Therapy — complimentary with every in-clinic IV session.
• Anti-inflammatory nutrition — omega-3 fatty acids, curcumin, and targeted elimination diets when indicated.
• Sleep optimization — poor sleep directly drives inflammatory markers higher; improving it amplifies HBOT results.
• Stress reduction — chronic cortisol elevation sustains inflammation; mind-body interventions complement cellular therapy.

If you are a concierge member, your physician coordinates all of these into a single integrated care plan.

Who Is a Candidate at TrufaMED

Adults with chronic inflammatory symptoms or conditions including (but not limited to) fibromyalgia, chronic pain syndromes, inflammatory bowel conditions in remission, post-viral inflammatory syndromes, and general systemic inflammation with elevated baseline markers may benefit from HBOT. You are NOT a candidate if you have an untreated pneumothorax, active lung disease (bullae, COPD exacerbation), active sinus or ear infection, uncontrolled high fever, or specific chemotherapy agents active in your system. Pregnancy is a relative contraindication for elective/wellness HBOT. Your physician performs a full physical examination, reviews your medical history and current medications, and completes an on-site chest X-ray before your first session — standard for all new HBOT patients at TrufaMED.

Real-World Case Scenarios

51-year-old with elevated CRP and joint stiffness

Baseline CRP 8.4 mg/L, morning joint stiffness >60 minutes. Completed 30-session protocol. CRP dropped to 1.9 mg/L at session 30; morning stiffness reduced to 15 minutes by session 20.

38-year-old with autoimmune-driven chronic inflammation

Worked alongside rheumatology while on biologic therapy. Noticed reduced flare frequency within 15 sessions. Inflammatory panel improved across the full 25-session protocol.

62-year-old with metabolic-inflammatory overlap

Paired HBOT with weight management and Iron Renew IV support. HbA1c improved from 6.2 to 5.7 over 8 weeks; hs-CRP dropped from 4.1 to 1.2 mg/L.

Referenced Research

• Thom SR. Hyperbaric oxygen — its mechanisms and efficacy.
• Tezgin D, et al. The effect of hyperbaric oxygen on mitochondrial and glycolytic energy metabolism.
• UHMS Indications for Hyperbaric Oxygen Therapy — Official Committee Statement.

More Questions Answered

Will HBOT interfere with my biologic or immunomodulator medication?

In most cases no — but your TrufaMED physician will review every medication during your initial evaluation and coordinate with your rheumatologist or specialist when indicated.

How will we know if HBOT is working on my inflammation?

Your physician will draw baseline inflammatory labs (hs-CRP, ferritin, and where indicated ESR, IL-6) and repeat them at sessions 15 and 30 to document objective change.

Can HBOT replace my anti-inflammatory medications?

HBOT is an adjunct, not a replacement. Many patients reduce medication needs during or after a protocol, but any changes are managed by your prescribing physician.

Real-World Case Scenarios

51-year-old with elevated CRP and joint stiffness

Baseline CRP 8.4 mg/L, morning joint stiffness >60 minutes. Completed 30-session protocol. CRP dropped to 1.9 mg/L at session 30; morning stiffness reduced to 15 minutes by session 20.

38-year-old with autoimmune-driven chronic inflammation

Worked alongside rheumatology while on biologic therapy. Noticed reduced flare frequency within 15 sessions. Inflammatory panel improved across the full 25-session protocol.

62-year-old with metabolic-inflammatory overlap

Paired HBOT with weight management and Iron Renew IV support. HbA1c improved from 6.2 to 5.7 over 8 weeks; hs-CRP dropped from 4.1 to 1.2 mg/L.

Referenced Research

• Thom SR. Hyperbaric oxygen — its mechanisms and efficacy.
• Tezgin D, et al. The effect of hyperbaric oxygen on mitochondrial and glycolytic energy metabolism.
• UHMS Indications for Hyperbaric Oxygen Therapy — Official Committee Statement.

More Questions Answered

Will HBOT interfere with my biologic or immunomodulator medication?

In most cases no — but your TrufaMED physician will review every medication during your initial evaluation and coordinate with your rheumatologist or specialist when indicated.

How will we know if HBOT is working on my inflammation?

Your physician will draw baseline inflammatory labs (hs-CRP, ferritin, and where indicated ESR, IL-6) and repeat them at sessions 15 and 30 to document objective change.

Can HBOT replace my anti-inflammatory medications?

HBOT is an adjunct, not a replacement. Many patients reduce medication needs during or after a protocol, but any changes are managed by your prescribing physician.

Common Questions About Chronic Inflammation

How many sessions before I see inflammation markers drop?

Most patients show measurable decline in CRP and ESR by session 10 to 15, with more substantial changes in TNF-alpha and IL-6 between sessions 15 and 25. Your physician will order repeat labs at these checkpoints.

Can HBOT replace my anti-inflammatory medication?

HBOT is not a replacement for prescribed medication. Do not change any medication without your prescribing physician. HBOT works alongside your existing treatment plan and, in some cases, may allow your physician to reduce dose over time based on your response.

What lab work should I bring?

If you have recent CRP, ESR, or condition-specific inflammatory panels, bring them to your initial consultation. If not, your TrufaMED physician will order baseline labs during your first visit.

Does HBOT help autoimmune conditions?

HBOT has been studied in several autoimmune contexts with encouraging directional data. It is not a cure, and patients with active autoimmune disease should be co-managed with their rheumatologist or specialist. At TrufaMED, we coordinate closely with your existing care team.

← Main HBOT Page